The insider selling is routine and quantitatively trivial relative to market cap. No bearish signal. Monitor upcoming earnings or product announcements for any fundamental changes, but this cluster alone does not warrant action.
GKOS drugs
GKOS drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 9 $155.07entry
- T+1 · 4mo ago −1.52%α −1.95% · $152.72
- T+5 · 4mo ago +0.21%α +0.34% · $155.39
- T+20 · 3mo ago +10.27%α +8.02% · $170.99
- T+60 · 7w ago +5.60%α +3.96% · $163.75
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two Glaukos insiders (CFO and Chief Development Officer) sold a combined $1.6M in shares over a 7-day window. The CFO's sale followed option exercises at $38.68, a typical same-day exercise-and-sell pattern. At $8.8B market cap, the total sales represent only ~0.018% of market cap, well below the 0.1% threshold for materiality. This is routine insider selling with no bearish signal.
Key Financial Metrics
Key Facts
- CFO Thurman Alex R. sold 10,000 shares at $150 on 2026-07-06 after exercising options at $38.68 (same-day exercise-and-sell).
- Chief Development Officer Navratil Tomas sold 716 shares at $139.06 on 2026-07-01.
- Total insider sales of $1.6M represent only ~0.018% of Glaukos' $8.8B market cap.
- Both sales are open-market sells; no insider purchases were reported in the cluster.
Financial Impact
Total insider sales of $1.6M, immaterial relative to $8.8B market cap.
Risk Factors
- Insider selling could increase if the stock continues to appreciate, but current levels are not alarming.
- Any future cluster with >0.5% of market cap sold would be more significant.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GKOS-1783559630432 |
Track record
16 reports on GKOS
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $242.67 Now $244.88 +0.91% settles Nov 23
- Nov 12, 20264d ago 144 Neutral 3/10 Entry $245.72 Now $244.88 −0.34% settles Nov 20
- Nov 6, 202610d ago 8-K Neutral 3/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $224.41 to $245.72 Now $244.88 +9.12% ▲ +9.50% +6.90% vs SPY
- Nov 4, 202612d ago 144 Neutral 2/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $246.70 to $247.16 Now $244.88 −0.74% ▲ +0.19% +1.10% vs SPY
- Oct 30, 202617d ago 144 Neutral 3/10 Entry $237.60 to $224.41 Now $244.88 +3.06% ▼ −5.55% −2.85% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $242.48 to $219.98 Now $244.88 +0.99% ▼ −9.28% −4.55% vs SPY
- Aug 13, 202613w ago Insider Cluster Neutral 3/10 Entry $184.53 to $184.89 Now $244.88 +32.70% ▲ +0.20% +1.56% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 2/10 Entry $186.63 to $189.55 Now $244.88 +31.21% ▲ +1.56% +2.01% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers